XML 26 R16.htm IDEA: XBRL DOCUMENT v3.24.2.u1
Share Options (Tables)
 6 Months Ended
Jun. 30, 2024
Share Options [Abstract]  
Schedule of Company’s Share Option Activity for Employees and Members of the Board of Directors The following table presents the Company’s share option activity for employees and members of the Board of Directors of the Company under the Plan for the periods of six months ended June 30, 2024 and 2023:
    Number of Share
Options		     Weighted Average
Exercise
Price		     Weighted
average
remaining
contractual
life		     Intrinsic
value		  
          $     (years)     $  
                         
Outstanding as of December 31, 2023     1,295,367       2.09       6.04       84  
Granted     48,600       4.32      
-
      
-
  
Exercised     (393,651 )     1.99      
-
      
-
  
Cancelled     (7,500 )     3.20      
-
      
-
  
Outstanding as of June 30, 2024 (unaudited)     942,816       2.24       6.71       2,811  
Exercisable as of June 30, 2024 (unaudited)     563,204       2.15       5.42       1,730  
    Number of Share
Options		     Weighted Average
Exercise
Price		     Weighted
average
remaining
contractual
life		     Intrinsic
value		  
          $     (years)     $  
                         
Outstanding as of December 31, 2022     1,570,991       1.78       4.97       2,435  
Granted     88,800       3.67       9.70      
-
  
Exercised     (18,448 )     1.50      
-
      
-
  
Forfeited or expired     (72,357 )     1.96      
-
      
-
  
Outstanding as of June 30, 2023 (unaudited)     1,568,986       1.88       4.85       1,475  
Exercisable as of June 30, 2023 (unaudited)     1,096,887       1.75       3.09       1,174  
Schedule of Outstanding and Exercisable Share Options Separated Ranges of Exercise Prices The outstanding share options as of June 30, 2024 have been separated into ranges of exercise prices, as follows:
 Exercise price   Share options
outstanding
as of
June 30,
2024		     Weighted
average
remaining
contractual
term		     Share options
exercisable
as of
June 30,
2024		     Weighted
average
remaining
contractual
term		  
    Unaudited  
          (years)           (years)  
-
     17,680       2.7       17,680       2.7  
1.14     84,080       2.34       84,080       2.34  
1.47     9,600       9.59      
-
      
-
  
1.48     50,000       9.21      
-
      
-
  
1.74     12,800       8.80       3,200       8.8  
1.83     573,454       7.03       354,325       6.31  
2.79     6,400       9.09      
-
      
-
  
3.20     5,002       7.15       3,439       7.15  
4.00     76,000       8.68       31,680       8.68  
4.17     28,800       1.53       28,800       1.53  
5.02     39,000       9.99      
-
      
-
  
5.12     40,000       5.04       40,000       5.04  
      942,816               563,204          
Schedule of Assumptions Used to Estimate the Fair Values of the Share Options Granted The following table presents the assumptions used to estimate the fair values of the share options granted in the reported periods presented:
    six-month period ended
June 30,		  
    2024     2023  
             
Volatility (%)     52.7%-73.5%       61.4%  
Risk-free interest rate (%)     4.0%-4.3%       3.7%-4.3%  
Dividend yield (%)    
-
      
-
  
Expected life (years)     6.25       6.25  
Exercise price ($)     1.47-5.02       1.74-4.00  
Share price ($)     1.72-4.96       1.74-3.73  
Schedule of Company’s Equity-Based Awards Recognized The total compensation cost related to all of the Company’s equity-based awards recognized in profit and loss during the periods of six months ended June 30, 2024 and 2023 was comprised as follows:
    Six-month period ended
June 30,		  
    2024     2023  
    Unaudited  
             
Research and development   $ 126     $ 122  
Sales and marketing     11       14  
General and administrative     48       40  
    $ 185     $ 176